EBERT CHARLES D 4
4 · WATSON PHARMACEUTICALS INC · Filed Feb 28, 2012
Insider Transaction Report
Form 4
EBERT CHARLES D
Sr. VP, Research & Development
Transactions
- Tax Payment
Common Stock, par value $0.0033
2012-02-24$58.17/sh−1,458$84,812→ 26,264 total
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.